It is anticipated that as is usually the case, financial motivation will move TZ from its current status potential anti-MDR/XDR agent, to one that will cure MDR and XDR TB. Foreword.
- Autores: Amaral, Leonard
- Journal: Recent Patents on Anti-Infective Drug Discovery
- Link: https://apps.webofknowledge.com/full_record.do?product=UA&search_mode=GeneralSearch&qid=4&SID=2CbhBUDoSw8ZkFBEQLW&page=1&doc=1